Alphanate in Immune Tolerance Induction Therapy
Public ClinicalTrials.gov record NCT03095287. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter Phase 2 Open-Label, Single-Arm, Prospective, Interventional Study of Plasma-Derived Factor VIII/VWF (Alphanate®) in Immune Tolerance Induction Therapy in Subjects With Congenital Hemophilia A
Study identification
- NCT ID
- NCT03095287
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Grifols Therapeutics LLC
- Industry
- Enrollment
- 2 participants
Conditions and interventions
Conditions
Interventions
- Alphanate Biological
Biological
Eligibility (public fields only)
- Age range
- Up to 12 Years
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2, 2018
- Primary completion
- Sep 17, 2020
- Completion
- Sep 17, 2020
- Last update posted
- Nov 22, 2021
2018 – 2020
United States locations
- U.S. sites
- 8
- U.S. states
- 7
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Emory University | Atlanta | Georgia | 30322 | — |
| University of Kentucky | Lexington | Kentucky | 40536 | — |
| Childrens Hospital and Clinics of Minnesota | Minneapolis | Minnesota | 55404 | — |
| The Childrens Mercy Hospital | Kansas City | Missouri | 64108 | — |
| Robert Wood Johnson Medical Group | New Brunswick | New Jersey | 08901 | — |
| Newark Beth Israel Medical Center & Children's Hospital of New Jersey | Newark | New Jersey | 07112 | — |
| University of North Carolina at Chapel Hill, Hemophilia and Thrombosis Center | Chapel Hill | North Carolina | 27517 | — |
| Seattle Children's Hospital, Seattle Children's Research Institute | Seattle | Washington | 98101 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03095287, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 22, 2021 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03095287 live on ClinicalTrials.gov.